UNSPSC 51203701: Gallium nitrate

This classification denotes a malignancy-associated hypercalcemia inhibitor with the molecular formula Ga.3NO3.9H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VRA0C6810N, chemically known as nitric acid, terbium(3+) salt but more generally known as gallium nitrate, which bears US NIH Compound Identifier 944. European Medicines Agency schedules Gallium nitrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13944MIG.

As of Q4 2014, GALLIUM NITRATE remains US FDA's Preferred Term for this commodity. Gallium nitrate bears US NLM identifiers UMLS ID C0061008 and NCI Concept Code C1109. SMILES: O[N](=O)O.

UNSPSC 51203701 Gallium nitrate is a Commodity code that shows minimal recent state and local procurement activity directly aligned with its chemical product scope. The recent opportunities tagged to this code actually solicit naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic pharmaceuticals and OTC products through cooperative purchasing, and pharmacy benefit program services—none of which are gallium nitrate or related inorganic chemicals. The mismatch suggests either miscoding in state and local procurement systems or that this Commodity code does not reflect active demand in the state and local market right now.

The issuing bodies in the recent opportunities span diverse public sectors: Seminole County, Florida (health services), the City of Tampa Fire Department (emergency response supplies), the Texas Health and Human Services Commission (pharmacy benefits), and the Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon (pharmaceuticals and OTC products through cooperative agreements). Geographic activity touches Florida, Texas, and Minnesota-based cooperative purchasing reaching broader state and local markets. The opportunities themselves—an IFB for naloxone procurement, an ITB for medical and first aid supplies with a $700,000 estimated value and an SLBE set-aside in Tampa, an RFI for direct-to-manufacturer prescription programs in Texas, and an RFP for generic multi-source pharmaceuticals through MMCAP with responses due March 26, 2026—are substantive, but none align with gallium nitrate procurement. Firms pursuing this code should verify the accuracy of the code assignment in actual bid documents rather than relying on UNSPSC metadata, as the recent record does not support active demand for the chemical product the code nominally covers.